Hiroyuki Nishiyama

机构：University of Tsukuba, University of Tsukuba Hospital · ORCID：0000-0001-7423-596X

发表论文 732 篇 · 总被引 11769 次 · h-index 50

代表论文

• ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer (2025 · New England Journal of Medicine · 被引 123)
• Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial (2025 · The Lancet · 被引 62)
• Real‐World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance (2025 · Cancer Medicine · 被引 5)
• Automated EMG-Based Classification of Upper Extremity Motor Impairment Levels in Subacute Stroke (2025 · Sensors · 被引 2)
• Protocol summary of a randomized controlled phase III trial for confirming the superiority of local radiotherapy for prostate cancer patients with high-volume metastasis sensitive to hormonal therapy: the JCOG2011 (HimeRT study) (2025 · Japanese Journal of Clinical Oncology · 被引 2)
• Very Low Uptake in Workplace Semen Analysis Research: Formative Web-Based Cross-Sectional Follow-Up Survey Distinguishing Employees With Self-Reported Unawareness From Aware Nonparticipants (2026 · JMIR Formative Research · 被引 1)